This publication provides 52 consensus recommendations by an expert panel on nutrition and lifestyle support for people using GLP‑1–based obesity therapies, addressing weight management, body composition, and common GI symptoms.
Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement
- 08/04/2025 - 12:00 am
Other content you might be interested in
Optimising Nutrition During GLP-1 RA Therapy for Weight Loss
In this education module, learn from expert metabolic health GP and dietitian Dr Terri-Lynne South on the nutritional risks, considerations and optimal dietary intake for patients on GLP-1 RA therapy for weight loss. Learning Objectives: Identify the nutritional risks associated with GLP-1 RA therapy for weight loss Summarise the nutritional requirements to be considered for individuals on GLP-1 RA therapy Outline how to optimise the nutrition of your patients who are prescribed GLP-1 RAs
Low Energy Diets for Obesity and CKD (SLOW-CKD Randomized Feasibility Study)
This study by Conley M et al. investigates the safety and feasibility of VLEDs in adults with obesity and CKD, offering fresh insights into how structured VLED programs and dietitian intervention—may support weight loss and potentially slow CKD progression.